2seventy bio, Inc

Constellation Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, specializing in the development of novel cancer therapies. The company focuses on targeting epigenetic pathways to discover and advance potential treatments for various types of cancer. Utilizing cutting-edge research and technology, Constellation Pharmaceuticals is dedicated to advancing the field of oncology through innovative drug discovery and development. The company's mission is to improve patient outcomes and make a meaningful impact in the fight against cancer. Generated from their business information

VBI Vaccines, based in Cambridge, MA, is a biopharmaceutical company focused on developing innovative vaccines and immunotherapies to address infectious diseases and cancer. With a strong emphasis on stimulating and fortifying the immune system, VBI is dedicated to overcoming public health challenges and improving overall health for all individuals. Utilizing their expertise in immunology and vaccinology, VBI's pipeline of vaccine and immunotherapeutic candidates is designed to both prevent and treat diseases by harnessing the power of the human immune system. Through their cutting-edge approach to virus-like particles, VBI aims to elicit natural and potent immune responses to combat a range of medical conditions, from highly contagious infectious diseases to fast-growing cancers.Generated from the website

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company based in Seattle, WA, specializing in the development of targeted therapies for rare respiratory diseases. Their focus lies in the treatment of interstitial lung diseases, including idiopathic pulmonary fibrosis, with their lead candidate, AP01, being a Phase 2b-ready inhaled formulation of pirfenidone. With a strong emphasis on improving patient quality of life, Avalyn Pharma is dedicated to developing inhaled formulations of approved medications to address the unmet needs of individuals suffering from rare lung diseases. Their innovative approach and recent advancements in clinical development have positioned them as a key player in the field of respiratory therapeutics.Generated from the website